Metastatic Kidney Medullary Carcinoma
3 clinical trials · Condition
◉ Watch Metastatic Kidney Medullary Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors (NCT03866382) | National Cancer Institute (NCI) | 2019-05-13 |
| Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer (NCT03587662) | M.D. Anderson Cancer Center | 2018-08-17 |
| Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic (NCT02721732) | M.D. Anderson Cancer Center | 2016-08-15 |
Track Metastatic Kidney Medullary Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.